Shopping Cart
Remove All
Your shopping cart is currently empty
Usmarapride free base (SUVN-D4010 free base) is a selective and orally active 5-HT4 receptor partial agonist, increasing soluble amyloid precursor protein α levels, useful in Alzheimer's disease research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $199 | - | In Stock |
| Description | Usmarapride free base (SUVN-D4010 free base) is a selective and orally active 5-HT4 receptor partial agonist, increasing soluble amyloid precursor protein α levels, useful in Alzheimer's disease research. |
| Targets&IC50 | 5-HT4 receptor:44 nM (EC50) |
| In vivo | Methods: Usmarapride free base (1 mg/kg, oral and 1 mg/kg, intravenous) was administered to male beagle dogs to evaluate the pharmacokinetics of Usmarapride free base. Results: Usmarapride free base was rapidly absorbed after oral administration (Tmax in the range of 0.5-0.75 hours), with oral exposure (AUC0-24h = 711 ± 369 ng·h/mL) and showed a long terminal venous half-life (6.0 ± 1.5 hours), moderate venous clearance (18 ± 6 mL/min/ kg) and volume of distribution (5.1 ± 0.6 L/kg), and an absolute oral bioavailability (%F) of 72 ± 11%.[1] |
| Synonyms | SUVN-D4010 free base, SUVN-D-1208045 free base, SUVN-D1003019 free base, SUVN-D 4010 free base, SUVN-1004028 free base, SUVN D4010 free base |
| Molecular Weight | 383.49 |
| Formula | C21H29N5O2 |
| Cas No. | 1428862-32-1 |
| Smiles | N=1N=C(OC1C2=NN(C=3C=CC=CC23)C(C)C)C4CCN(CCCOC)CC4 |
| Relative Density. | 1.26 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (208.61 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (8.61 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.